The CBD.fr team has translated the MARIJUANA DAILY BUSINESS article into French for your convenience… you will find the origin of this article written by .
Germany imported 1,759 kilograms (3,878 pounds) of medical cannabis flower for pharmacy distribution during the third quarter of 2020, according to new data from the Federal Institute for Medicines and Medical Devices (BfArM).
This represents a 28% decrease compared to the previous quarter, but 34% less than in the same quarter last year.
However, for the period January-September, imports are up 15% compared to the first nine months of 2019.
Import data is a relevant metric for companies involved in the German medical marijuana market, as the flower category is entirely dependent on imports and – as Marijuana Business Daily first reported – this trend will continue at least until the end of the first quarter of 2021.
Flower sales account for more than half of the German medical marijuana market.
Imported quantities fluctuate considerably throughout the year, so they are difficult to predict and do not necessarily reflect changes in domestic sales – which means that conclusions should not be drawn from import data alone.
Not all imported flowers are intended for German consumers.
Some could have been destroyed – for example, if they had not been sold before the end of their shelf life – or re-exported to other European countries, including the Czech Republic, Italy, Luxembourg, Malta, Poland and the United Kingdom.
Two important indicators of market trends include:
- Reimbursement data, which recently fell for the first time on a quarterly basis.
- How are individual refund requests evolving, a situation recently updatedby MJBizDaily .
It is still unclear how the year will end, but the current situation indicates that year-on-year growth in 2020 will not be as spectacular as in previous years.
Since the start of the current medical marijuana program in early 2017, the flower market doubled in 2018 and again in 2019.
The MJBizDaily report on European medical cannabis , published in May, predicts the following for the 2020 market:
Slower year-on-year growth should not be surprising. At the time of writing, the supply situation in Germany was relatively good. The strong growth from 2018 to 2019 could be partly explained by an undersupplied market in 2018. Maintaining the same year-on-year growth rate in 2020 will be difficult after a better-supplied market in 2019.
Also read:
-
German legislation on cannabis
-
Germany firmly rejects the bill to legalize recreational marijuana as hopes for reform fade
Co-founder of CBD.fr
Julien Cordobes is the editor of CBD.fr. Born in 1978 in the Paris region, he first trained in e-commerce before turning to natural health approaches, a dual perspective that now structures his way of writing about cannabidiol: reading the scientific literature as it is, without hardening the conclusions, and presenting it in a language that everyone understands.
He discovered CBD at a time when the French market was developing faster than the information available to it. He acquired CBD.fr in 2022 and then took on editorial responsibility for the blog. Since then, he has published numerous articles covering the daily use of CBD, the interpretation of laboratory analyses, the evolution of the legal framework, and precautions for use.
